時富集團(01049.HK)指員工接種每劑疫苗後可獲一日疫苗假期
時富集團(01049.HK)公布,聯同旗下公司包括時富金融、實惠集團、時富量化金融,響應政府呼籲,參加「全城起動,快打疫苗」行動。
集團僱員在接種每劑疫苗後,將獲得一日疫苗假期,讓他們有充足休息。同時為了肯定較早前已接種疫苗的僱員對疫苗接種計劃的支持,所有在5月31日或之前已接種疫苗的僱員,可就每劑疫苗申請在今年12月31日之前放一日疫苗假期。
董事長關百豪指,希望這項行動可以鼓勵同事接種疫苗,保障同事以及顧客的健康;不少醫學專家都已表明,高接種率對全社會公共衛生健康有積極正面作用,也希望藉此為香港締造有利的營商環境。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.